| Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
|---|---|
| Contact name | Christine Sethna |
| Contact phone | 718-470-3423 |
| Contact email | csethna@nshs.edu |
| Dua signed dt | June 17, 2010, midnight |
| PI name | Christine Sethna, Howard Trachtman |
| Site approved dt | Feb. 4, 2010, midnight |
| Niddk signed dt | July 14, 2010, midnight |